PSI CRO expands in RTP, outlines growth into 2018

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Hankimage9)
(Image: iStock/Hankimage9)

Related tags: Research triangle park

PSI CRO has purchased new office space in Research Triangle Park (RTP) as the company expects to grow locally and globally in 2018.

PSI is a privately-owned, full-service contract research organization (CRO) headquartered in Switzerland.

When the company made the move to RTP in 2016, Kayt Leonard, public relations specialist, PSI CRO, told us the CRO planned to occupy the building space for several years.

However, by the third quarter of 2017, the company outgrew this facility and has since purchased a new space in the area, which Leonard said can accommodate three times the amount of staff currently employed.

The company will move into the new offices in Durham following renovations, which are expected to be completed in the second quarter of 2018.

PSI opened several new offices throughout 2017, including those in Sydney, Seoul​, Taipei​, and Madrid​. It also moved its San Francisco-based operations to a larger office in the greater SFO area.

Olga Alfonsova, head of corporate development at PSI CRO said in Septembe​r that the company is “perfectly on track​” with its plans to expand in Asia Pacific.

Hong Kong will be the next opening Alfonsova explained, with an opening expected early next year.

In 2018, we’ll continue to grow both locally and abroad​,” Leonard said.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars